In The News Posted November 10, 2020 Share Posted November 10, 2020 HUDDINGE, Sweden, Nov. 10, 2020 /PRNewswire/ -- Continued focus on MIV-818 July – September Significant events during the quarter In July, a research collaboration was initiated with the Drug Discovery and Development Platform (DDD) at SciLifeLab on potential inhibitors of SARS CoV-2....View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.